You are here

kidney disease

As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease

Fierce Pharma

Fri, 11/3/23 - 10:53 am

Travere Therapeutics

IgA nephropathy

Omeros terminates kidney disease trial as therapy fails in late-stage study

Reuters

Mon, 10/16/23 - 10:15 am

clinical trials

Berger's disease

AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million

Forbes

Tue, 10/3/23 - 11:34 am

Novartis eyes accelerated FDA approval for iptacopan across multiple indications

Clinical Trials Arena

Mon, 10/2/23 - 10:14 am

clinical trials

IgA nephropathy

Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks

BioSpace

Thu, 09/21/23 - 06:34 pm

Travere Therapeutics

clinical trials

ProKidney drops $25.5M on North Carolina manufacturing site for cell therapy prospect

Fierce Pharma

Wed, 06/14/23 - 06:48 pm

drug manufacturing

Novartis to acquire kidney disease biotech Chinook for up to $3.5B

BioPharma Dive

Mon, 06/12/23 - 10:24 am

Chinook Therapeutics

HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions

Fierce Biotech

Tue, 04/11/23 - 11:36 am

Human Immunology Bioscience

Goldfinch Bio falls from the sky after failing to find a path forward for kidney treatments

Fierce Biotech

Sun, 01/29/23 - 01:22 pm

As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data

Endpoints

Mon, 11/7/22 - 05:24 pm

Ionis Pharmaceuticals

Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease

MedCity News

Tue, 11/1/22 - 10:55 am

Human Immunology Bioscience

autoimmune disease

Tricida’s shares plunge as phase 3 fail seals fate of FDA-rejected kidney disease drug

Fierce Biotech

Mon, 10/24/22 - 11:59 am

FDA’s liver safety request set to delay decision on Travere’s kidney drug

Fierce Biotech

Sun, 10/16/22 - 05:12 pm

Travere Therapeutics

Regulus reports positive findings from Phase I kidney disease trial

Clinical Trials Arena

Tue, 09/13/22 - 10:36 am

clinical trials

Where Will Vertex Pharmaceuticals Be in 1 Year?

Motley Fool

Tue, 08/23/22 - 10:38 am

Vertex Pharmaceuticals

cystic fibrosis

Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment

Fierce Biotech

Fri, 08/19/22 - 10:47 am

chronic kidney disease

Travere fails to convince regulators to consider accelerated approval for a rare kidney disease — again

Endpoints

Thu, 08/4/22 - 10:56 am

Travere Therapeutics

Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a new type of anticoagulant

Fierce Biotech

Thu, 07/28/22 - 05:54 pm

Ionis Pharmaceuticals

clinical trials

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?

MedCity News

Mon, 07/25/22 - 10:33 am

Sanofi walks away from kidney disease therapy, leaving $25M in milestones out of reach for Regulus

Fierce Biotech

Tue, 07/19/22 - 10:21 am

Pages